| __timestamp | Agios Pharmaceuticals, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 152500000 |
| Thursday, January 1, 2015 | 141827000 | 187800000 |
| Friday, January 1, 2016 | 220163000 | 184000000 |
| Sunday, January 1, 2017 | 292681000 | 167700000 |
| Monday, January 1, 2018 | 341324000 | 218600000 |
| Tuesday, January 1, 2019 | 410894000 | 187400000 |
| Wednesday, January 1, 2020 | 367470000 | 177700000 |
| Friday, January 1, 2021 | 256973000 | 122000000 |
| Saturday, January 1, 2022 | 279910000 | 123100000 |
| Sunday, January 1, 2023 | 288903000 | 122500000 |
| Monday, January 1, 2024 | 301286000 |
Unlocking the unknown
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Agios Pharmaceuticals, Inc. and Perrigo Company plc have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Agios Pharmaceuticals has consistently increased its R&D spending, peaking in 2019 with a 310% rise from its 2014 levels. This commitment underscores Agios's dedication to pioneering new treatments and therapies.
Conversely, Perrigo Company plc has maintained a more stable R&D expenditure, with a slight decline of around 20% from 2014 to 2023. This strategy reflects Perrigo's focus on optimizing existing product lines while cautiously exploring new opportunities.
As the pharmaceutical industry continues to innovate, these companies' R&D strategies offer valuable insights into their future trajectories.
Research and Development Investment: Eli Lilly and Company vs Perrigo Company plc
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Perrigo Company plc
Comparing Innovation Spending: Ascendis Pharma A/S and Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Corcept Therapeutics Incorporated vs Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc
R&D Spending Showdown: Perrigo Company plc vs MannKind Corporation
Perrigo Company plc vs Wave Life Sciences Ltd.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Agios Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Comparing Innovation Spending: Agios Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.